Finance

Lists
CERO:OTCMKTS
CERo Therapeutics Holdings Inc
$0.010
+3.70%
(+0.00037) 1D
Sep 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CERO...
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
742.81K
Avg. vol.
661.24K
Volume
401.18K
52-wk high
$5.72
52-wk low
$0.01
EPS
-$13.23
Beta
0.22
Shares outstanding
71.63M
No. of employees
8
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
742.81K
Avg. vol.
661.24K
Volume
401.18K
52-wk high
$5.72
52-wk low
$0.01
EPS
-$13.23
Beta
0.22
Shares outstanding
71.63M
No. of employees
8
About CERo Therapeutics Holdings Inc
CEO-
Employees8
Founded2020
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecero.bio
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
500.00K
105.42K
-
-
Cost of revenue
500.00K
105.42K
-
-
Research and development expenses
2.39M
629.07K
2.34M
1.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.98M
3.80M
2.51M
2.11M
Operating expense
4.36M
4.43M
4.85M
3.85M
Total operating expenses
4.86M
4.53M
4.85M
3.85M
Operating income
-4.86M
-4.53M
-4.85M
-3.85M
Other non operating income
248.00
-6.00
-896.55K
-3.10M
EBT including unusual items
-4.86M
-4.54M
-5.89M
-1.03M
EBT excluding unusual items
-4.86M
-4.54M
-5.91M
-7.64M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.86M
-4.54M
-5.89M
-1.03M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
5.94K
-
3.15K
1.02K
Interest expense
-
-8.95K
-166.29K
-690.04K
Net interest expenses
5.94K
-8.95K
-163.14K
-689.02K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.79M
-4.46M
-4.78M
-3.79M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps